Search our news, events & opinions

On 1 September 2016 Withy King LLP merged with Royds LLP. The trading name for the merged firm is Royds Withy King. All content produced prior to this date will remain in the name of the firms pre-merger.

16 April 2014 0 Comments
Posted in Corporate & Commercial, Opinion

Leading Drug Company Faces Bribery Allegations

Author headshot image Posted by , Partner

On April 14th it was reported that a leading UK drug company was facing criminal investigations in Poland, following allegations that it had been bribing doctors.

According to the reports, which follow a BBC investigation, the drug company had paid the doctors in return promoting the drug, which led to prescriptions; and it has been revealed that eleven doctors and a regional manager for the drug company are facing charges relating to alleged bribery over a two year period.

If the allegations are proved to be correct, the drug company are likely to have broken both the UK Bribery Act and the US Foreign Corrupt Practices Act; whilst the doctors and regional manager involved could face prison sentences ranging from six months to eight years.

This is not the first time that the company have faced such allegations, having been under a similar investigation in China last year; whilst earlier this month, the drug company confirmed that it was investigating allegations of similar behaviour in Iraq.

Whilst the drug company have confirmed that they are cooperating with Poland’s Central Anti-Corruption Office; for those businesses who face allegations relating to bribery offences, our corporate and commercial solicitors in London may be able to assist.

To find out how, contact our partner Claus Anderson, or partner and head of our corporate and commercial team, John North.

Leave a comment

Thank you for choosing to leave a comment. Please keep in mind that comments are moderated and please do not use a spammy keyword or a domain as your name or it will be deleted.




Corporate & Commercial

Our corporate lawyers will get you the right deal and protect your business, now and in the future.

Learn more


T: 020 7842 1462 (DDI)

Search our news, events & opinions